Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD as of 10 September, 2025
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 9 September, 2025
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD as of 9 September, 2025
Notification for sale of treasury shares as of 9 September 2025
Sofia, Bulgaria, September 9, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 5, 2025 the Company sold 22 113 (twenty-two thousand one hundred and thirteen) treasury shares representing 0.004% of the share capital of the Company, at a total value of BGN 60 741.75 on the Bulgarian Stock Exchange, the average price per share was BGN 2.75.
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 5 September, 2025
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 5 September, 2025
Notification of sale of treasury shares as of September 5, 2025
Sofia, Bulgaria, September 5, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 4, 2025 the Company sold 67 700 (sixty-seven thousand seven hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 184 903.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.73.